摘要
目的探讨术中氩靶向冷冻治疗系统(即氩氦刀)治疗晚期胰腺癌的安全性及疗效。方法 2001—2002年期间8例晚期胰腺癌使用了术中氩氦刀治疗。结果 8例晚期胰腺癌病人中,平均生存期为8.6个月,1例目前仍然存活。5例腹痛病人,3例完全缓解,2例部分缓解;1例腰背痛病人,疼痛部分缓解。结论术中氩氦刀治疗尽管不能明显延长晚期胰腺癌病人的平均生存期,但能明显缓解病人的疼痛,提高病人的生活质量,仍不失为一种有效的晚期胰腺癌的姑息治疗方法。
Objective To investigate the efficacy and safety of intraoperative Ar-He targeted cryoablation in patients with unresectable pancreatic carcinoma. Methods The clinical data of 8 patients with advanced unresectable pancreatic carcinoma receiving intraoperative Ar-He targeted cryoablation in our hospital from 2001 to 2002 were retrospectively analyzed. Results The average survival time for the 8 patients was 8. 6 months. One patient is still alive now. In the 5 patients with abdominal pain, the abdominal pain disappeared in 3 patients and partially alleviated in the other 2 after intraoperative cryoablation. Back pain also partially alleviated in 1 patient. Conclusions Though the survival time of the patients with unresectable pancreatic carcinoma undergoing intraoperative cryoablation is not prolonged, Ar-He targeted cryoablation is a good palliative therapy for the disease because it not only relieves pain but also improve the patientg life quality.
出处
《中华肝胆外科杂志》
CAS
CSCD
2006年第3期186-187,共2页
Chinese Journal of Hepatobiliary Surgery
关键词
胰腺肿瘤
氩氦刀
冷冻治疗
Pancreatic neoplasms
Ar-He knife
Cryoablation
